DaVita Inc. reported its financial results for the quarter ended September 30, 2026, with consolidated revenues of $3.578 billion. Operating income for the quarter was $499 million and adjusted operating income was $561 million. The company reported diluted earnings per share of

DaVita Inc. Reports Third Quarter 2026 Results and Updates 2026 Guidance

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.38% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%.  December E-mini S&P futures (ESZ26 ) rose +0.33%, and December E-mini...

Stocks Finish Mostly Higher on Earnings Optimism

Key PointsAmerican Express is the last remaining credit card stock in Berkshire's portfolio.

3 Berkshire Hathaway Holdings to Buy While They Sit at Least 15% Below Their Highs

DaVita has delivered a strong 87.2% share price gain over the past three years, which naturally raises a question for anyone looking at the stock today. Is the current valuation still grounded in the earnings power of the dialysis provider, or has the share price moved ahead of what the business is generating? A roughly 87.2% return over three years puts real weight on whether DaVita's earnings profile can support the price investors are paying today. The business leans on recurring...

DaVita (DVA) Stock May Be Undervalued On Its Earnings Power

Key PointsDaVita reported double-digit EPS growth in the second quarter.

This Warren Buffett Stock Is Up 58%. History Says This Is What Happens Next.

DaVita has made Berkshire Hathaway a lot of money. Is Berkshire likely to hold onto the stock?

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc. News